Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

formation and notes required by generally accepted accounting principles in the United States for complete financial statements. NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share information)(Unaudited)Three Months EndedNine Months EndedSeptember 30, September 30,2011201020112010Revenue:Product sales and royalties

$  10,222$  7,230$  26,023$  21,968License, collaboration and other

16,84630,69529,67591,757Total revenue

27,06837,92555,698113,725Operating costs and expenses:Cost of goods sold

5,0386,24516,44115,430Research and development

31,01827,72493,46476,610General and administrative

12,35010,18135,26229,401Total operating costs and expenses

48,40644,150145,167121,441Loss from operations

(21,338)(6,225)(89,469)(7,716)Non-operating income (expense):Interest income

6223691,5831,225Interest expense

(2,543)(2,826)(7,698)(8,686)Other income (expense), net

(717)249(599)436Total non-operating expense

(2,638)(2,208)(6,714)(7,025)Loss before provision for income taxes

(23,976)(8,433)(96,183)(14,741)Provision for income taxes

92278300617Net loss

$ (24,068)$ (8,711)$ (96,483)$ (15,358)Basic and diluted net loss per share

$
(0.21)$   (0.09)$
(0.86)$
(0.16)Weighted average shares outstanding used in computing basic and diluted net loss per share

114,41394,213112,43593,972NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited)Nine Months Ended September 30,20112010Cash flows from operating activities:Net loss

$   (96,483)$ (15,358)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization

11,42412,499Stock-based compensation

14,50112,716Other non-cash transactions

967(176)Changes in operating assets and liabilities:Accounts receivable

12,188(752)Inventory'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Calif. , Oct. 24, 2014  America,s ... over friendly robotic competition at the  Medical Design ... on October 29-30 th at the ... will highlight local student built robots from the ... (FIRST) competition.  FIRST students and mentors will offer ...
(Date:10/25/2014)... 24, 2014  The National Association of Drug ... achieved by Kentucky,s real-time, ... The National Precursor Log Exchange (NPLEx) system automatically ... sale and helps flag meth offenders for law ... up NPLEx "watch lists" that notify them via ...
(Date:10/25/2014)... CUPERTINO, Calif. , Oct. 24, 2014 ... ) third quarter 2014 financial results press release, you ... will be broadcast live over the internet on Monday, ... pm Pacific Time). A live audio webcast ... homepage at http://www.durect.com and clicking "Investor Relations."  ...
Breaking Medicine Technology:Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Kentucky's NPLEx Technology Making Significant Progress 2DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
... a study published in The American Journal of ... Clinic psychiatrist Mark Frye, M.D., attempted to identify what ... to experience treatment-emergent mania (TEM).Bipolar disorder, also known as ... mood instability that can be serious and disabling. The ...
Cached Medicine Technology:New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 3
(Date:10/25/2014)... York (PRWEB) October 25, 2014 ... lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston ... in U.S. District Court, Southern District of West ... Judgment on Punitive Damages in a group of ... a ruling issued on October 21st, U.S. District ...
(Date:10/25/2014)... 2014 Limbkeepers® announced today that they ... with Ed Begley Jr, airing 1st QTR 2015 via ... this episode, Innovations will focus on Limbkeepers® non compression ... thinning skin on arms, hands, and legs from abrasion, ... versatile products, which help reduce injuries, allow for continued ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... FRIDAY, Oct. 24, 2014 (HealthDay News) -- Researchers ... say their findings are cause for concern. ... that are raised for human consumption contribute to ... health, according to background information from the study. ... germs sicken about 2 million people and kill ...
(Date:10/25/2014)... Current osteoporosis screening guidelines and tools fail to ... osteoporosis-related fractures, a new study says. "If ... that help us accurately predict who will suffer ... these at-risk people for preventive measures," study author ... division of general internal medicine and health services ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
... Oct. 10 The Johns Hopkins University School,of ... Adjuvant Breast Cancer Strategies: From Biomarkers to Treatment,Selection," ... latest advances in,breast cancer treatment., In recent ... have,led to chemotherapeutic and biologic treatment combinations that ...
... Course for,Non-Dermatologists about Detection and Management of Melanoma, ... the Royal Sonesta Hotel Boston,Cambridge, MA, CONCORD, ... England and the Boston University School of Medicine ... course to update non-dermatologists on the detection and ...
... Nature,s Way Holding Company, a,subsidiary of ... producer of clinically proven phytomedicines, has reached,agreement ... Therapy with North,Castle Partners, LLC, the controlling ... to other shareholders delivering their signatures and,provides ...
... 38 studies found painkillers showed protective effect , , THURSDAY, ... are associated with a reduced risk for breast cancer, ... an invitation for all women to start popping the ... that to happen here, for people to jump on ...
... care, deliver higher, levels of documentation accuracy, and increase staff ... ... PITTSBURGH, Oct. 9 Vocollect Healthcare Systems, Inc.,announces that Community ... care as part of its,strategic initiative to deliver the utmost ...
... 9 ATS Medical, Inc.,(Nasdaq: ATSI ), ... today that it will participate at the Second,Annual ... Astoria,in New York. Michael Dale, President and CEO ... Time on Monday, October 13, 2008., (Logo: ...
Cached Medicine News:Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2Health News:Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Nature's Way Holding, Inc. 2Health News:Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Nature's Way Holding, Inc. 3Health News:NSAIDs Might Lower Breast Cancer Risk 2Health News:NSAIDs Might Lower Breast Cancer Risk 3Health News:Community Eldercare Services LLC Deploys Voice-Assisted Care to Revolutionize Care Across Its 20-Facility Enterprise 2Health News:Community Eldercare Services LLC Deploys Voice-Assisted Care to Revolutionize Care Across Its 20-Facility Enterprise 3Health News:ATS Medical to Participate at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2
... watt halogen light source with ... ,SOLOS Endoscopy shares your commitment ... the highest quality care available ... development of advanced surgical instruments ...
Linvatecs single CCD camera heads offer high resolution with the convenience of programmable buttons for sterile field control of the printer and VCR. Available in "V and "C mount in NTSC and PAL....
... camera system offers the latest technology ... controller. Equipped with many of the ... expensive camera controllers, including edge enhancement, ... The controller is compatible and interchangeable ...
... Camera Systems provide the advanced functionality ... need for advanced training. Programmable, easy ... the flexibility needed to accommodate the ... Compatible with both autoclavable and non-autoclavable ...
Medicine Products: